- Friday, May 3
- 1:05 PM - 2:05 PM
In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.
Describe and contrast the mechanism of action of naltrexone and acamprosate in the treatment of alcohol use disorder
Use buprenorphine/naloxone to treat opioid use disorder
Download a PDF of Presented SlidesDOWNLOAD